Erythrocyte membrane fatty acid content in infants consuming formulas supplemented with docosahexaenoic acid (DHA) and arachidonic acid (ARA): an observational study
Authors:
- 16 September 2010
- journal article
- Published by Wiley in Maternal & Child Nutrition
- Vol. 6 (4) , 338-346
Abstract
In this observational study, we compared erythrocyte membrane fatty acids in infants consuming formula supplemented with docosahexaenoic acid (DHA) and arachidonic acid (ARA) with those consuming other types of milks. In 110 infants who were participants in a cohort study of otherwise healthy children at risk for developing type 1 diabetes, erythrocytes were collected at approximately 9 months of age, and fatty acid content was measured as a percentage of total lipids. Parents reported the type of milk the infants consumed in the month of and prior to erythrocyte collection: infant formula supplemented with ARA and DHA (supplemented formula), formula with no ARA and DHA supplements (non‐supplemented formula), breast milk, or non‐supplemented formula plus breast milk. Membrane DHA (4.42 versus 1.79, P < 0.001) and omega‐3 fatty acid (5.81 versus 3.43, P < 0.001) levels were higher in infants consuming supplemented versus non‐supplemented formula. Omega‐6 fatty acids were lower in infants consuming supplemented versus non‐supplemented formula (26.32 versus 29.68, P = 0.023); ARA did not differ between groups. Infants given supplemented formula had higher DHA (4.42 versus 2.81, P < 0.001) and omega‐3 fatty acids (5.81 versus 4.45, P = 0.008) than infants drinking breast milk. In infants whose mothers did not receive any dietary advice, use of supplemented formula is associated with higher omega‐3 and lower omega‐6 fatty acid status.Keywords
This publication has 29 references indexed in Scilit:
- IPD meta‐analysis shows no effect of LC‐PUFA supplementation on infant growth at 18 monthsActa Paediatrica, 2008
- Longchain polyunsaturated fatty acid supplementation in preterm infants2008
- Fish oil and mental health: the role of n-3 long-chain polyunsaturated fatty acids in cognitive development and neurological disordersInternational Clinical Psychopharmacology, 2006
- Formula Supplemented with Docosahexaenoic Acid (DHA) and Arachidonic Acid (ARA): A Critical Review of the ResearchJournal for Specialists in Pediatric Nursing, 2006
- Growth and development of preterm infants fed infant formulas containing docosahexaenoic acid and arachidonic acidThe Journal of Pediatrics, 2005
- Longchain polyunsaturated fatty acid supplementation in preterm infants2004
- Incidence of Insulin-Dependent Diabetes Mellitus in ColoradoEpidemiology, 1992
- Essential fatty acids in growth and developmentProgress in Lipid Research, 1991
- The Essentiality of N-3 Fatty Acids for the Development and Function of the Retina and BrainAnnual Review of Nutrition, 1988
- A RAPID METHOD OF TOTAL LIPID EXTRACTION AND PURIFICATIONCanadian Journal of Biochemistry and Physiology, 1959